Exicure (XCUR) Operating Income (2016 - 2026)
Exicure's (XCUR) quarterly Operating Income came in at -$1.6 million in Q1 2026, down 156.11% YoY from $2.9 million in Q1 2025, and up 27.3% on a QoQ basis from -$2.3 million in Q4 2025.
Exicure (XCUR) Operating Income (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Operating Income data on file, last reported at -$1.6 million in Q1 2026.
- Quarterly Operating Income fell 156.11% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.8 million (down 3.81% YoY) and the FY2025 annual result came in at -$4.2 million, up 65.39% from the prior year.
- Operating Income climbed to -$1.6 million in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $18.6 million in Q4 2022 to a low of -$7.7 million in Q1 2022.
- A 5-year average of -$2.1 million and a median of -$2.5 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income sank 406.61% — and 2025, when it soared 449.64%.
- Tracing XCUR's Operating Income over 5 years: stood at $18.6 million in 2022, then plunged by 108.06% to -$1.5 million in 2023, then slumped by 406.61% to -$7.6 million in 2024, then soared by 70.27% to -$2.3 million in 2025, then grew by 27.3% to -$1.6 million in 2026.
- The last three Operating Income figures came in at -$1.6 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.64 Mn |
| Dec 31, 2025 | -2.26 Mn |
| Sep 30, 2025 | -2.39 Mn |
| Jun 30, 2025 | -2.51 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | -2.57 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -836,000.00 |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | -3.32 Mn |
| Jun 30, 2023 | -5.64 Mn |
| Mar 31, 2023 | -4.54 Mn |
| Dec 31, 2022 | 18.59 Mn |
| Sep 30, 2022 | -5.21 Mn |
| Jun 30, 2022 | -7.48 Mn |
| Mar 31, 2022 | -7.74 Mn |
| Dec 31, 2021 | -13.45 Mn |
| Sep 30, 2021 | -23.08 Mn |
| Jun 30, 2021 | -13.86 Mn |